Hummel M, Ansonoff M A, Pintar J E, Unterwald E M
Department of Pharmacology and The Center for Substance Abuse Research, Temple University School of Medicine, 3420 North Broad Street, MRB 324, Philadelphia, PA 19140, USA.
Neuroscience. 2004;125(1):211-20. doi: 10.1016/j.neuroscience.2004.01.025.
Cocaine-induced behavioral sensitization is a complex phenomenon involving a number of neuromodulator and neurotransmitter systems. To specifically investigate the role of the micro opioid receptor (MOR) in cocaine-induced behavioral sensitization in mice, both genetic and pharmacological approaches were undertaken. MOR-1 deficient mice of varying backgrounds (C57BL/6J, 129S6, F1 hybrid 129S6xC57BL/6J and 129S6xC57BL/6J) and wild-type C57BL/6J mice exposed continuously to naltrexone, an opioid receptor antagonist, received single daily injections of saline or cocaine for 10 days. All mice received a single cocaine challenge 7 days following the last saline or cocaine injection to test for the expression of sensitization. The locomotor-stimulating and sensitizing effects of cocaine observed in MOR-1 wild-type mice were absent in MOR-1 knockout mice maintained on the mixed 129S6xC57BL/6J background. In contrast, MOR-1 deficient mice developed on a C57BL/6J background showed an accentuated sensitivity to cocaine-induced locomotion. Cocaine's psychomotor activating effects were more pronounced in the MOR-1 C57BL/6J knockouts injected daily with cocaine than in the MOR-1 wild-type mice. Similar locomotor-stimulating and sensitizing effects were found in both F1 hybrid 129S6xC57BL/6J MOR-1 wild-type and MOR-1 knockout mice, while the 129S6 strain showed an overall indifference to cocaine. That is, both the locomotor-stimulating and sensitizing effects of cocaine were absent in both MOR-1 wild-type and MOR-1 knockout mice maintained on the 129S6 background. Lastly, the locomotor-stimulating and sensitizing effects of cocaine were attenuated in C57BL/6J wild-type mice exposed continuously to naltrexone. Collectively, these data support a role for opioidergic involvement in cocaine-influenced behavior in mice. Moreover, MORs appear to differentially modulate a sensitized response to cocaine in different strains of mice as delineated by MOR-1 gene deletion and pharmacological antagonism.
可卡因诱导的行为敏化是一种复杂的现象,涉及多种神经调质和神经递质系统。为了具体研究微小阿片受体(MOR)在小鼠可卡因诱导的行为敏化中的作用,采用了遗传学和药理学方法。对不同背景(C57BL/6J、129S6、F1杂交种129S6xC57BL/6J和129S6xC57BL/6J)的MOR-1基因缺陷小鼠以及持续接受阿片受体拮抗剂纳曲酮处理的野生型C57BL/6J小鼠,每天注射一次生理盐水或可卡因,持续10天。在最后一次注射生理盐水或可卡因7天后,所有小鼠接受一次可卡因激发试验,以检测敏化的表达情况。在维持129S6xC57BL/6J混合背景的MOR-1基因敲除小鼠中,未观察到MOR-1野生型小鼠中出现的可卡因的运动刺激和敏化作用。相比之下,在C57BL/6J背景上培育的MOR-1基因缺陷小鼠对可卡因诱导的运动表现出增强的敏感性。每天注射可卡因的MOR-1 C57BL/6J基因敲除小鼠中,可卡因的精神运动激活作用比MOR-1野生型小鼠更明显。在F1杂交种129S6xC57BL/6J的MOR-1野生型和MOR-1基因敲除小鼠中都发现了类似的运动刺激和敏化作用,而129S6品系对可卡因总体上无反应。也就是说,在维持129S6背景的MOR-1野生型和MOR-1基因敲除小鼠中,可卡因的运动刺激和敏化作用均不存在。最后,持续接受纳曲酮处理的C57BL/6J野生型小鼠中,可卡因的运动刺激和敏化作用减弱。总体而言,这些数据支持阿片能系统参与小鼠可卡因影响行为的作用。此外,如通过MOR-1基因缺失和药理学拮抗所描述的,MORs在不同品系小鼠中似乎对可卡因的敏化反应有不同的调节作用。